Abstract
This article will review the available clinical data on the efficacy of trastuzumab in the treatment of both early advanced breast cancer.
MeSH terms
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / genetics
-
Chemotherapy, Adjuvant
-
Disease Progression
-
Female
-
Follow-Up Studies
-
Genes, erbB-2
-
Humans
-
Neoplasm Recurrence, Local / drug therapy*
-
Neoplasm Recurrence, Local / genetics
-
Trastuzumab
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Trastuzumab